← All diseases

Inborn errors of metabolism

Argininosuccinic aciduria (ASA)

An inherited urea cycle disorder. The body cannot get rid of the nitrogen left over from protein. Ammonia builds up in the blood and can affect the brain.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

Orphanet has a guideline for emergency doctors for this disease (language: French). See on Orphanet

Prepare an emergency card

This page is translated from the Turkish original.

This disease is followed through the “Inborn errors of metabolism” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

When the body uses protein, it makes a waste product called nitrogen. The liver turns this waste into urea and removes it in the urine. In this disease, an enzyme needed for this job is missing. Nitrogen builds up in the blood as ammonia. When there is too much ammonia, it harms the brain most of all.

Which symptoms can occur?

The severe form often begins in the first days after birth. The mild form may appear later and come in attacks.

  • In a baby: poor feeding, vomiting and unusual sleepiness
  • Fast breathing and seizures (fits)
  • A large liver and, over time, liver damage
  • Dry, brittle hair that breaks easily
  • Developmental delay and learning difficulties
  • High blood pressure (sometimes)
  • Ammonia attacks during illness or stress

How is it diagnosed?

The levels of ammonia and amino acids in the blood are measured. Argininosuccinic acid is found to be high in the blood or urine. The diagnosis can be confirmed with a genetic test. In some countries, it is found through newborn screening.

Treatment and care

Care is led by a metabolic team. The main approach is a special diet that limits protein. Extra amino acid supplements and treatments that help remove nitrogen are used. If ammonia rises very high, hospital treatment is needed; sometimes blood dialysis is done. A liver transplant may be considered for some people. The blood, liver and blood pressure are checked regularly. Physiotherapy and speech therapy support development. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

The disease is passed on through recessive inheritance. The mother and father are usually healthy carriers. For a couple who are both carriers, the chance of having an affected child is 1 in 4 in each pregnancy. In marriages between relatives, the chance of carrying the same gene is higher. Genetic counselling is recommended for the family.

Source: MedlinePlus Genetics: Argininosuccinic aciduria · NORD: Argininosuccinic Aciduria · Orphanet: Argininosuccinic aciduria (ORPHA:23)

Key facts

How common is it?
Prevalence: 1-9 per 100 000 (Europe)
How is it inherited?
Autosomal recessive
When does it usually start?
Any age
Gene(s) involved
ASL

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

For all rare diseases: Nadir Hastalıklar Federasyonu

Links checked on October 8, 2026.

Guides related to this disease

  • Special diets and medical nutrition · Metabolic diet, blood monitoring, medical formula and SGK report, sick-day plan, tube feeding and swallowing problems, school meals, supplement warning
  • Rare disease at school · Telling the school, medicines and emergency plan, inclusion and BEP, support education room, absences, LGS/YKS arrangements, peer bullying.

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about ASA

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

Questions you can ask your doctor

  • Could this trial be suitable for us?
  • If we take part, how would current treatment and check-ups be affected?
  • Where does the trial take place, and how are travel and accommodation handled?
  • What happens if we want to leave the trial?

ClinicalTrials.gov lists 1 active interventional study for this disease. None is recruiting right now; none has a site in Türkiye. Last checked: October 7, 2026.

Selected records (studies with a site in Türkiye first):

See all studies on ClinicalTrials.gov · Joining clinical trials

Inborn errors of metabolism: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:23 · ICD-11 5C50.A0

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.